These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33310661)

  • 1. Identification and validation of L Antigen Family Member 3 as an immune-related biomarker associated with the progression of papillary thyroid cancer.
    Dong X; Yang Q; Gu J; Lv S; Song D; Chen D; Song J; Zhang X; Huang D
    Int Immunopharmacol; 2021 Jan; 90():107267. PubMed ID: 33310661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
    Dong X; Gu DN; Wang O; Ye Z
    Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer.
    Dong X; Lv S; Gu D; Zhang X; Ye Z
    Front Oncol; 2020; 10():553628. PubMed ID: 33552947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z; Liu Y; Ma M; Chang L
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis.
    Dong X; Lv S; Zhang X; Hao R
    Int Immunopharmacol; 2020 Aug; 85():106599. PubMed ID: 32438075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
    Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
    Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.
    He J; Jin Y; Zhou M; Li X; Chen W; Wang Y; Gu S; Cao Y; Chu C; Liu X; Zou Q
    Cancer Sci; 2018 Mar; 109(3):642-655. PubMed ID: 29274137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
    Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
    Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression.
    Wei H; Pan L; Tao D; Li R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):56-61. PubMed ID: 29842886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
    Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
    Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
    Sun J; Shi R; Zhao S; Li X; Lu S; Bu H; Ma X; Su C
    J Exp Clin Cancer Res; 2017 Mar; 36(1):40. PubMed ID: 28270228
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wen J; Lin B; Lin L; Chen Y; Wang O
    Aging (Albany NY); 2020 Aug; 12(16):16437-16456. PubMed ID: 32857728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
    Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
    Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
    Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.